Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract Surgery

Clinical trial NCT00198445 · COMPLETED

Trial details

NCT number: NCT00198445
Sponsor: Bausch & Lomb Incorporated
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Postoperative Complications Cataract

Start date: 2003-05-01
Primary completion: 2004-01-01
Enrollment: 527

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.